Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment (Q86300844)
Jump to navigation
Jump to search
scientific article published on 06 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment |
scientific article published on 06 March 2013 |
Statements
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment (English)
Cornelia Tillack
Laura Maximiliane Ehmann
Matthias Friedrich
Rüdiger P Laubender
Pavol Papay
Harald Vogelsang
Johannes Stallhofer
Florian Beigel
Andrea Bedynek
Martin Wetzke
Harald Maier
Maria Koburger
Johanna Wagner
Jürgen Glas
Julia Diegelmann
Sarah Koglin
Jürgen Schauber
Andreas Wollenberg